Identification of a RING protein that can interact in vivo with the BRCA1 gene product
- 1 December 1996
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 14 (4), 430-440
- https://doi.org/10.1038/ng1296-430
Abstract
The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that contains the cysteine-rich RING motif, a zinc-binding domain found in a variety of regulatory proteins. Here we describe a novel protein that interacts in vivo with the N-terminal region of BRCA1. This BRCA1-associated RING domain (BARD1) protein contains an N-terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1. The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1.Keywords
This publication has 30 references indexed in Scilit:
- Does this have a familiar RING?Trends in Biochemical Sciences, 1996
- Murine Brca1: sequence and significance for human missense mutationsHuman Molecular Genetics, 1995
- Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.Genes & Development, 1995
- Isolation of the Mouse Homologue of BRCA1 and Genetic Mapping to Mouse Chromosome 11Genomics, 1995
- GAL4 fusion vectors for expression in yeast or mammalian cellsGene, 1992
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990
- Basic Local Alignment Search ToolJournal of Molecular Biology, 1990
- Basic local alignment search toolJournal of Molecular Biology, 1990
- A novel genetic system to detect protein–protein interactionsNature, 1989
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988